WASHINGTON (MedPage Today) — An FDA advisory committee will meet later this week to review whether the antidepressant duloxetine (Cymbalta) should be used as a treatment for chronic pain despite risks that include liver damage and skin disease.
No Comments »
Filed under: General Health News
(MedPage Today) — Admitting mistakes to patients won’t automatically increase malpractice costs, researchers found.
No Comments »
Filed under: General Health News
(MedPage Today) — The Florida Medical Association (FMA) has voted to send a “no confidence” letter to leaders of the American Medical Association (AMA) — saying that the AMA leadership has “failed to represent practicing physicians on the issue of healthcare reform.”
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A rift has developed over language in the healthcare reform law mandating how much money insurers must devote to patient care and in how federal taxes paid by insurers are treated in determining the formula.
No Comments »
Filed under: General Health News
Palatin Technologies, Inc. today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood pressure [...]
No Comments »
Filed under: Pharmacy News
Xenon Pharmaceuticals Inc. announced today that it has initiated a phase 2 clinical trial evaluating its novel topical XEN402 therapy for the treatment of PHN.
No Comments »
Filed under: Pharmacy News
Hospitals participating in a Premier healthcare alliance quality improvement program have saved more than $284 million over the past year through improvements in clinical performance and enhancements in professional practice evaluation.
No Comments »
Filed under: Pharmacy News
Today, Intercell AG announced its financial results for Q2 and H1 2010.IXIARO/JESPECT sales increased significantly from EUR 2.4m in Q2 2009 to EUR 5.2m in Q2 2010 Continued focus on growing marketing and sales of product in traveler and military markets
No Comments »
Filed under: Pharmacy News
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular disease, today announces that the key scientific work underlying its lead pharmaceutical product C-Cure(R), a revolutionary stem cell treatment for heart failure, has been published in the Journal of the American College of Cardiology (JACC). The findings were described [...]
No Comments »
Filed under: Pharmacy News
An experimental drug called olaparib has been shown to shrink tumours in women whose advanced cancers were caused by faults in their BRCA genes.
No Comments »
Filed under: Pharmacy News
